BMY
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company historical holders
total: 20
Bares Capital Management Bristol-Myers Squibb Company transactions over time
- Total transactions:
- 4
- New positions:
- 2
- Sold out:
- 2
- Held since:
- 2014 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2015 Q1
Bares Capital Management has been an institutional investor in Bristol-Myers Squibb Company (BMY) since 2013 Q4. According to 2025 Q3 report, Bares Capital Management doesn't hold any shares. The fund/company first acquired BMY in 2013 Q4, initially purchasing 3,834 shares. Bares Capital Management later completely sold out the position and reinvested in BMY again in 2014 Q4. Since the initial investment, Bares Capital Management has made 3 more transactions in this position.
When did Bares Capital Management exit their BMY position?
Bares Capital Management no longer holds Bristol-Myers Squibb Company (BMY). They sold off their entire position in 2015 Q1, closing out an investment that began in 2013 Q4.
When did Bares Capital Management first invest in BMY?
Bares Capital Management first invested in Bristol-Myers Squibb Company (BMY) in 2013 Q4 at the reported quarter-end price of $53.21 per share, acquiring 3,834 shares in their initial purchase.
What is Bares Capital Management's average cost basis for BMY?
Based on historical transaction data, Bares Capital Management's estimated cost basis for Bristol-Myers Squibb Company (BMY) is approximately $58.95 per share. This represents their average reported price* across all buy transactions.
Has Bares Capital Management reinvested in BMY after selling?
Yes, Bares Capital Management has shown renewed interest in Bristol-Myers Squibb Company (BMY). After completely selling their position, they reinitiated an investment in 2014 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $58.95
- Weighted AVG sell price:
- $58.95
BMY transactions history by Bares Capital Management
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2015 Q1
|
0.00%
|
$58.95
|
-100% (-3,834)
|
|||
|
2014 Q4
|
0.03%
|
$58.95
|
new
|
|||
|
2014 Q1
|
0.00%
|
$53.21
|
-100% (-3,834)
|
|||
|
2013 Q4
|
0.02%
|
$53.21
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.